MG
TVTY

Michael Gelband’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Michael Gelband’s Portfolio TVTY Stock Details TVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,332
Closed -$365K – 2746
2022
Q1 		$365K Buy
+11,332
New +$306K ﹤0.01% 1686
2021
Q3 		– Sell
-26,370
Closed -$694K – 2871
2021
Q2 		$694K Sell
26,370
-4,133
-14% -$104K 0.01% 1194
2021
Q1 		$681K Buy
30,503
+18,358
+151% +$421K 0.01% 1151
2020
Q4 		$238K Sell
12,145
-6,374
-34% -$106K ﹤0.01% 1647
2020
Q3 		$260K Buy
+18,519
New +$267K 0.01% 1350
2019
Q3 		– Sell
-26,800
Closed -$441K – 1737
2019
Q2 		$441K Buy
+26,800
New +$517K 0.02% 520

Other funds holding TVTY

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Michael Gelband's TVTY Position: Q2 2022 in Review

Michael Gelband sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 11,332 shares — an estimated $365K sold.

Michael Gelband first reported a position in TVTY in Q2 2019 and held it in 6 quarters. The position peaked at $694K in Q2 2021. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Michael Gelband reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Michael Gelband sold 11,332 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $365K.
  • Michael Gelband first reported a position in Tivity Health, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Michael Gelband's Tivity Health, Inc. Common Stock position peaked at $694K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.